Chemed Corporation reported a 2.1% increase in revenue to $533 million. GAAP diluted EPS increased by 75.8% to $6.96, and adjusted diluted EPS increased by 21.6% to $5.13. VITAS segment revenue declined by 2.3%, while Roto-Rooter's revenue increased by 10.2%.
Consolidated revenue increased by 2.1% to $533 million.
GAAP diluted EPS increased by 75.8% to $6.96.
Adjusted diluted EPS increased by 21.6% to $5.13.
Roto-Rooter revenue increased by 10.2% to $201 million.
Chemed provided guidance for the full year 2021, anticipating challenges due to the COVID-19 pandemic. VITAS is expected to experience a revenue decline and ADC decrease, while Roto-Rooter is forecasted to achieve revenue growth. Full-year adjusted earnings per diluted share are estimated to be in the range of $17.00 to $17.50.
Visualization of income flow from segment revenue to net income